Csenge Advisory Group Becton Dickinson & CO Transaction History

Csenge Advisory Group

$1.97 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$254.9 - $283.59 $6,372 - $7,089	25 Added 1.51%	1,676 $433,000
Q2 2023 Jul 20, 2023	SELL	$238.39 - $265.32 $14,780 - $16,449	-62 Reduced 3.62%	1,651 $435,000
Q1 2023 May 01, 2023	BUY	$229.71 - $259.35 $25,957 - $29,306	113 Added 7.06%	1,713 $424,000
Q4 2022 Feb 10, 2023	BUY	$218.29 - $256.91 $146,036 - $171,872	669 Added 71.86%	1,600 $407,000
Q3 2022 Oct 04, 2022	BUY	$51.03 - $264.23 $1,735 - $8,983	34 Added 3.79%	931 $207,000
Q2 2022 Jul 27, 2022	BUY	$234.74 - $275.42 $8,920 - $10,465	38 Added 4.42%	897 $221,000
Q1 2022 May 09, 2022	BUY	$243.64 - $270.48 $209,286 - $232,342	859 New	859 $228,000
Q2 2020 Jul 17, 2020	SELL	$219.9 - $263.41 $218,140 - $261,302	-992 Closed	0 $0
Q1 2020 Apr 21, 2020	SELL	$195.69 - $279.01 $57,337 - $81,749	-293 Reduced 22.8%	992 $228,000
Q4 2019 Feb 05, 2020	BUY	$236.45 - $266.82 $18,916 - $21,345	80 Added 6.64%	1,285 $349,000
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $27,439 - $30,473	119 Added 10.96%	1,205 $305,000
Q2 2019 Jul 30, 2019	BUY	$217.4 - $246.08 $41,088 - $46,509	189 Added 21.07%	1,086 $2.73 Million
Q1 2019 May 07, 2019	SELL	$206.05 - $248.17 $1,442 - $1,737	-7 Reduced 0.77%	897 $224,000
Q4 2018 Feb 07, 2019	BUY	$204.73 - $257.93 $5,732 - $7,222	28 Added 3.2%	904 $203,000
Q3 2018 Nov 19, 2018	SELL	$233.07 - $256.0 $66,891 - $73,472	-287 Reduced 24.68%	876 $206,000
Q2 2018 Aug 10, 2018	SELL	$208.1 - $233.85 $24,555 - $27,594	-118 Reduced 9.21%	1,163 $279,000
Q1 2018 May 10, 2018	BUY	$205.46 - $240.27 $263,194 - $307,785	1,281 New	1,281 $278,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account